Izotropic Corporation (CSE:IZO)
Canada · Delayed Price · Currency is CAD 0.3050
0.00 (0.00%)
At close: Dec 5, 2025
Izotropic Company Description
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers.
The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast.
Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation
| Country | Canada |
| Founded | 2016 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Robert Thast |
Contact Details
Address: 800-15355 24th Avenue Surrey, V4A 2H9 Canada | |
| Phone | (833) 496-2677 |
| Website | izocorp.com |
Stock Details
| Ticker Symbol | IZO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| ISIN Number | CA46604F1099 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Robert Louis Thast | Founder, Interim Chief Executive Officer and Chairman |
| Ralph F. Proceviat CPA | Chief Financial Officer and Director |
| Dr. Younes Achkire Ph.D. | Executive Vice President of Product Engineering and Chief Operating Officer |
| Ali Reza Sodagar | Legal Advisor and Independent Director |
| Dr. Andrew M. Hernandez | Head of Imaging Technology |
| Jaclyn Thast | Operations Manager and Corporate Secretary |